Profession Concentration Focus

Profession Concentration Focus

To be an in-depth & trust-worthy CRO partner
Scientific & Rigorous, in search of excellence

Scientific & Rigorous, in search of excellence

Innovation & Change,high-efficiency operation
Integrity  Profession  Win-win Cooperation

Integrity Profession Win-win Cooperation

To provide excellent services and products

Who We Are

Beijing Hope Pharmaceutical Co., Ltd., established in 2005, is a high-tech enterprise with "chemical drug research and development" as its core capability. Hope has over 16 years of experience in project evaluation, innovation-oriented patent around design, pre-clinical development, clinical trial practice, registration, marker authorization, etc.. Project schedule, quality, life cycle, and registration success rate has been ensured under the orderly and well-defined R&D management system. Based on clinical and customer needs, our products related to multiple indications such as anti-tumor, anti-depression, anti-epileptic, anti-anxiety, cardiovascular, cerebrovascular, digestive & respiratory system, and API, oral solid & liquid preparations, injections and so on dosage form included.

  • 16

    years

    Focus on medicine development

  • 100

    +

    More than 100+ technology transfer succeeded

  • 30

    +

    Over 30+ invention patents applied

  • 20

    +

    More than 20+ series of products commercialized

Milestones

Now
2020
2019
2018
2017
2016
2015
2013
2012
2011
2008
2007
2006
2005
prev
next
• National High-tech Enterprise Awarded for 15 consecutive years
• Top 20 Chinese Pharmaceutical R&D Companies Awarded for three consecutive years
• 30+ Invention Patents Applied
• 70+ clinical & Production & New Drug Certifications Approved
• 10+ International Registration (EU, FDA, etc. ) Submitted
• 100+ Technology Transfer Finished
• 20+ Series products commercialized
prev
next
• Jinghai Industrial Park R&D Center Operated
• Strategic Partnership with Zezheng Pharmaceutical Established
prev
next
• Subsidiary HMYA Established, International Business Operated Independently
• EU & FDA Application Submitted
• Top 20 Chinese Pharmaceutical R&D Companies Awarded (Reelected)
• CSAIII Pilot
• T100 New Technology & New Product Innovation Action Outstanding Enterprise Awarded
prev
next
• Strategic Partnership with PPC Group Established
• Top 20 Chinese Pharmaceutical R&D Companies Awarded (Reelected)
prev
next
• Strategic Partnership with Porton Pharmaceutical Established
• Top 20 Chinese Pharmaceutical R&D Companies Awarded
prev
next
• Subsidiary HMY Established, CRO Business Operated Independently

prev
next
• Subsidiary HMT Established, The Raw Materials & Intermediates Business Operated Independently
• Employee Stock Ownership Platform Established, Shareholding Reform Finished
prev
next
• The First Patent Certificate Awarded
prev
next
• The First New Drug Certificate Acquired
• Technology R & D Institution (Beijing) Awarded
• Audited by Foreign Clients
prev
next
• Equity Investment in Shandong Confucius Pharmaceutical
prev
next
• Strategic Partnership with Peking Chemical Heng-ye Established
prev
next
• National High-tech Enterprise Awarded
prev
next
• New Drug R & D Center Established
prev
next
• Hope Pharmaceutical Founded

News & Events

Hope

Subsidiaries

Beijing HMT Medical Technology Co., Ltd.
API & intermediate business

Beijing HMY Medical Technology Co., Ltd.
CRO business

Beijing HMYA Medical Technology Co., Ltd.
International business

  

Beijing Hope Pharmaceutical Co., Ltd.   京ICP备17065299号

这是描述信息